Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 3
1995 2
1996 3
1997 7
1998 3
1999 6
2000 7
2001 10
2002 10
2003 17
2004 15
2005 8
2006 11
2007 13
2008 8
2009 15
2010 13
2011 16
2012 17
2013 16
2014 15
2015 18
2016 27
2017 23
2018 15
2019 12
2020 17
2021 19
2022 12
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

315 results
Results by year
Filters applied: . Clear all
Page 1
Cytomegalovirus breakthrough and resistance during letermovir prophylaxis.
Perchetti GA, Biernacki MA, Xie H, Castor J, Joncas-Schronce L, Ueda Oshima M, Kim Y, Jerome KR, Sandmaier BM, Martin PJ, Boeckh M, Greninger AL, Zamora D. Perchetti GA, et al. Among authors: boeckh m. Bone Marrow Transplant. 2023 Jan 24. doi: 10.1038/s41409-023-01920-w. Online ahead of print. Bone Marrow Transplant. 2023. PMID: 36693927
Letermovir is a relatively new antiviral for prophylaxis against cytomegalovirus (CMV) after allogeneic hematopoietic cell transplantation (HCT). CMV-seropositive HCT recipients who received letermovir prophylaxis from 2018 to 2020 at our center were evaluated for letermov …
Letermovir is a relatively new antiviral for prophylaxis against cytomegalovirus (CMV) after allogeneic hematopoietic cell transplantatio
Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation.
Ueda Oshima M, Xie H, Zamora D, Flowers ME, Hill GR, Mielcarek M, Sandmaier BM, Gooley TA, Boeckh MJ. Ueda Oshima M, et al. Among authors: boeckh mj. Blood Adv. 2023 Jan 3:bloodadvances.2022009112. doi: 10.1182/bloodadvances.2022009112. Online ahead of print. Blood Adv. 2023. PMID: 36595478
The kinetics of early and late CMV reactivation after hematopoietic cell transplantation using various methods of graft-versus-host-disease (GVHD) prophylaxis are poorly defined. ...Transplantation occurred between 2007-2018; CMV-monitoring/management followed unifo …
The kinetics of early and late CMV reactivation after hematopoietic cell transplantation using various methods of graft-versus-host-d …
BK Viremia and Changes in Estimated Glomerular Filtration Rate in Children and Young Adults after Hematopoietic Cell Transplantation.
Wychera C, Imlay HN, Duke ER, Faino A, Li-Huang M, Stevens-Ayers T, Davis C, Lange-Sperandio B, Mallhi KK, Hill JA, Boeckh M, Englund JA, Hingorani S. Wychera C, et al. Among authors: boeckh m. Transplant Cell Ther. 2022 Dec 7:S2666-6367(22)01784-5. doi: 10.1016/j.jtct.2022.11.023. Online ahead of print. Transplant Cell Ther. 2022. PMID: 36494016
Kidney disease in allogeneic hematopoietic cell transplantation (HCT) recipients is associated with increased mortality rates. ...
Kidney disease in allogeneic hematopoietic cell transplantation (HCT) recipients is associated with increased mortality rates. ...
How I Prevent Viral Reactivation in High-risk Patients.
Dadwal SS, Papanicolaou G, Boeckh M. Dadwal SS, et al. Among authors: boeckh m. Blood. 2022 Dec 9:blood.2021014676. doi: 10.1182/blood.2021014676. Online ahead of print. Blood. 2022. PMID: 36493341
Preventing viral infections at an early stage is a key strategy of successfully improving transplant outcomes. Preemptive therapy and prophylaxis using antiviral agents have been used successfully to prevent clinically significant viral infections in hematopoietic cell …
Preventing viral infections at an early stage is a key strategy of successfully improving transplant outcomes. Preemptive therapy and …
Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology.
Khawaja F, Papanicolaou G, Dadwal S, Pergam SA, Wingard JR, Boghdadly ZE, Abidi MZ, Waghmare A, Shahid Z, Michaels L, Hill JA, Kamboj M, Boeckh M, Auletta JJ, Chemaly RF. Khawaja F, et al. Among authors: boeckh m. Transplant Cell Ther. 2023 Jan;29(1):10-18. doi: 10.1016/j.jtct.2022.10.010. Epub 2022 Oct 21. Transplant Cell Ther. 2023. PMID: 36273782 Free PMC article.
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), disproportionately affects immunocompromised and elderly patients. Not only are hematopoietic cell transplantation (HCT) and chimeric antigen receptor (CAR) T-cell …
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), disproportionately affects immu …
Depletion of exhausted alloreactive T cells enables targeting of stem-like memory T cells to generate tumor-specific immunity.
Minnie SA, Waltner OG, Ensbey KS, Nemychenkov NS, Schmidt CR, Bhise SS, Legg SRW, Campoy G, Samson LD, Kuns RD, Zhou T, Huck JD, Vuckovic S, Zamora D, Yeh A, Spencer A, Koyama M, Markey KA, Lane SW, Boeckh M, Ring AM, Furlan SN, Hill GR. Minnie SA, et al. Among authors: boeckh m. Sci Immunol. 2022 Oct 21;7(76):eabo3420. doi: 10.1126/sciimmunol.abo3420. Epub 2022 Oct 14. Sci Immunol. 2022. PMID: 36240285
Some hematological malignancies such as multiple myeloma are inherently resistant to immune-mediated antitumor responses, the cause of which remains unknown. Allogeneic bone marrow transplantation (alloBMT) is the only curative immunotherapy for hematological malignancies …
Some hematological malignancies such as multiple myeloma are inherently resistant to immune-mediated antitumor responses, the cause of which …
Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022).
Dioverti V, Boghdadly ZE, Shahid Z, Waghmare A, Abidi MZ, Pergam S, Boeckh M, Dadwal S, Kamboj M, Seo S, Chemaly RF, Papanicolaou GA. Dioverti V, et al. Among authors: boeckh m. Transplant Cell Ther. 2022 Dec;28(12):810-821. doi: 10.1016/j.jtct.2022.09.002. Epub 2022 Sep 11. Transplant Cell Ther. 2022. PMID: 36103987 Free PMC article.
Exposure to antibiotics with anaerobic activity before respiratory viral infection is associated with respiratory disease progression after hematopoietic cell transplant.
Ogimi C, Krantz EM, Golob JL, Liu C, Waghmare A, Akramoff A, Mallory A, Leisenring WM, Jerome KR, Chow VA, Pergam SA, Fredricks DN, Englund JA, Boeckh M. Ogimi C, et al. Among authors: boeckh m. Bone Marrow Transplant. 2022 Dec;57(12):1765-1773. doi: 10.1038/s41409-022-01790-8. Epub 2022 Sep 5. Bone Marrow Transplant. 2022. PMID: 36064752
We examined associations between specific antibiotic exposures and progression to lower respiratory tract disease (LRTD) following individual respiratory viral infections (RVIs) after hematopoietic cell transplantation (HCT). We analyzed allogeneic HCT recipients of all ag …
We examined associations between specific antibiotic exposures and progression to lower respiratory tract disease (LRTD) following individua …
Clinical and Economic Burden of Multiple Double-Stranded DNA Viral Infections after Allogeneic Hematopoietic Cell Transplantation.
Hill JA, Moon SH, Chandak A, Zhang Z, Boeckh M, Maziarz RT. Hill JA, et al. Among authors: boeckh m. Transplant Cell Ther. 2022 Sep;28(9):619.e1-619.e8. doi: 10.1016/j.jtct.2022.06.016. Epub 2022 Jun 25. Transplant Cell Ther. 2022. PMID: 35764288 Free article.
Conditioning regimens for allogeneic hematopoietic cell transplantation (allo-HCT) are immunosuppressive and increase the risk for reactivation of and infection with double-stranded DNA (dsDNA) viruses, which contribute to morbidity and mortality after allo-HCT. ...For all …
Conditioning regimens for allogeneic hematopoietic cell transplantation (allo-HCT) are immunosuppressive and increase the risk for re …
Correlation of initial upper respiratory tract viral burden with progression to lower tract disease in adult allogeneic hematopoietic cell transplant recipients.
Ogimi C, Xie H, Waghmare A, Jerome KR, Leisenring WM, Milano F, Englund JA, Boeckh M. Ogimi C, et al. Among authors: boeckh m. J Clin Virol. 2022 Jun;150-151:105152. doi: 10.1016/j.jcv.2022.105152. Epub 2022 Apr 4. J Clin Virol. 2022. PMID: 35447514 Review.
BACKGROUND: Some respiratory viruses have been evaluated for the association between viral burden and respiratory disease progression in hematopoietic cell transplant (HCT) recipients, and no significant association has been reported. ...STUDY DESIGN: We reviewed adult all …
BACKGROUND: Some respiratory viruses have been evaluated for the association between viral burden and respiratory disease progression in hem …
315 results